ARCHIVES

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White

November 30, 1984

Journal Editors Were Unaware Of Tobacco Funding.

March 28, 2008

ASTRO Members Approve Governance, Dues Changes

January 17, 2003

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

In Brief: Schmidt Has Doubts About Community Saturation Program; Diane Fink Wins Gerard Lambert Award

July 25, 1975